380 related articles for article (PubMed ID: 6315763)
1. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
[TBL] [Abstract][Full Text] [Related]
2. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of neurotensin and pancreatic polypeptide in man: role of the kidney and plasma factors.
Shulkes A; Bijaphala S; Dawborn JK; Fletcher DR; Hardy KJ
J Clin Endocrinol Metab; 1984 May; 58(5):873-9. PubMed ID: 6707191
[TBL] [Abstract][Full Text] [Related]
4. Characterization of immunoreactive forms of pancreatic polypeptide in islet cell tumors using antisera with different regional specificities.
O'Hare MM; Huda I; Sloan JM; Kennedy TL; Buchanan KD
Cancer; 1985 May; 55(9):1895-8. PubMed ID: 2983868
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome.
Brunt LM; Mazoujian G; O'Dorisio TM; Wells SA
Surgery; 1994 Mar; 115(3):362-9. PubMed ID: 8128360
[TBL] [Abstract][Full Text] [Related]
6. Presence of neurotensin and neuromedin-N within a common precursor from a human pancreatic neuroendocrine tumor.
Carraway RE; Mitra SP; Feurle GE; Hacki WH
J Clin Endocrinol Metab; 1988 Jun; 66(6):1323-8. PubMed ID: 3131383
[TBL] [Abstract][Full Text] [Related]
7. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma.
Lee YC; Allen JM; Uttenthal LO; Walker MC; Shemilt J; Gill SS; Bloom SR
J Clin Endocrinol Metab; 1984 Jul; 59(1):45-50. PubMed ID: 6725524
[TBL] [Abstract][Full Text] [Related]
8. Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin.
Gutniak M; Rosenqvist U; Grimelius L; Lundberg JM; Hökfelt T; Rökaeus A; Rosell S; Lundqvist G; Fahrenkrug J; Sundblad R; Gutniak E
Acta Med Scand; 1980; 208(1-2):95-100. PubMed ID: 7001860
[TBL] [Abstract][Full Text] [Related]
9. VIPoma syndrome.
Krejs GJ
Am J Med; 1987 May; 82(5B):37-48. PubMed ID: 3035922
[TBL] [Abstract][Full Text] [Related]
10. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
[TBL] [Abstract][Full Text] [Related]
11. Watery diarrhea syndrome caused by multihormonal malignant pancreatic islet cell tumor secreting somatostatin, vasoactive intestinal peptide, serotonin, and prostaglandin E--a clinicopathological, biochemical, immunohistochemical, and ultrastructural study.
Chen YF; Liu TH; Chen SP; Pan GZ; Lu XH; Lu GJ; Zhong SX; Cai LX; Cui QC; Ran QY
Pancreas; 1986; 1(1):80-9. PubMed ID: 2883647
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
Sheu HW; Chou SY; Yang KC; Kao CR; Yang TL; Shih CC
Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):931-5. PubMed ID: 2559939
[TBL] [Abstract][Full Text] [Related]
13. Preoperative localization of a vasoactive intestinal peptide-secreting tumor by transhepatic portal venous sampling.
Parkman HP; Malet PF; Ogorek CP; Burke DR; Deveney CW
Am J Gastroenterol; 1988 May; 83(5):559-63. PubMed ID: 2834945
[TBL] [Abstract][Full Text] [Related]
14. Two patients with pancreatic apudomas secreting neurotensin and VIP.
Bloom SR; Lee YC; Lacroute JM; Abbass A; Sondag D; Baumann R; Weill JP
Gut; 1983 May; 24(5):448-52. PubMed ID: 6840620
[TBL] [Abstract][Full Text] [Related]
15. Expression of neurotensin in endocrine tumors.
Kapuscinski M; Shulkes A; Read D; Hardy KJ
J Clin Endocrinol Metab; 1990 Jan; 70(1):100-6. PubMed ID: 2403568
[TBL] [Abstract][Full Text] [Related]
16. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
White A; Tan K; Gray C; Roberts I; Ratcliffe JG
Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
[TBL] [Abstract][Full Text] [Related]
17. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor.
Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208
[TBL] [Abstract][Full Text] [Related]
18. Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors.
Fahrenkrug J; Pedersen JH
Peptides; 1986; 7(5):717-21. PubMed ID: 3797338
[TBL] [Abstract][Full Text] [Related]
19. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
